SCHEMBL15712422

SCHEMBL15712422

COC(=O)c1cc(-n2ccc3cc(Nc4ccc(Cl)cc4C(=O)OC)ccc32)ccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 0.41
KMT2A Q03164 9/20 0.41
LMNA P02545 6/20 0.41
MAPT P10636 4/20 0.41
HTT P42858 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
POLB P06746 1/20 0.39
ROCK2 O75116 1/20 0.39
PIM1 P11309 1/20 0.39
PIM3 Q86V86 1/20 0.39
HPGD P15428 3/20 0.38
ALDH1A1 P00352 3/20 0.38
TP53 P04637 1/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
AGPAT2 O15120 1/20 0.38
GFER P55789 1/20 0.36
GAA P10253 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15712223 0.92 MEN1 (0.45) MEN1KMT2ALMNAMAPTPOLB
SCHEMBL15712742 0.88 ALDH1A1 (0.43) MEN1KMT2ALMNAMAPTHTT
SCHEMBL15712310 0.88 DHODH (0.46) MEN1KMT2ALMNAMAPTPOLB
SCHEMBL15712432 0.87 ALDH1A1 (0.45) MEN1KMT2ALMNAMAPTPOLB
SCHEMBL15712337 0.86 KCNMA1 (0.41) MEN1KMT2ALMNAMAPTPOLB
SCHEMBL15712226 0.83 DHODH (0.41) MEN1KMT2ALMNAMAPTPOLB
SCHEMBL15712114 0.83 MPO (0.52) MEN1KMT2ALMNAMAPTPOLB
SCHEMBL15712737 0.81 MEN1 (0.39) MEN1KMT2ALMNAMAPTHTT
SCHEMBL15712449 0.81 TMPRSS4 (0.43) MEN1KMT2AHTTPOLBHPGD
SCHEMBL15712736 0.80 ABL1 (0.41) MEN1KMT2ALMNAMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2915804-B1 NOVEL AMINE DERIVATIVE OR SALT THEREOF AS TNF ALPHA INHIBITORS FUJIFILM TOYAMA CHEMICAL CO LTD (JP) 2019-03-27 EP disclosed
EP-2915804-B1 NOVEL AMINE DERIVATIVE OR SALT THEREOF AS TNF ALPHA INHIBITORS FUJIFILM TOYAMA CHEMICAL CO LTD (JP) 2019-03-27 EP disclosed
US-9624215-B2 Amine derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2017-04-18 US disclosed
US-9624215-B2 Amine derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2017-04-18 US disclosed
US-20150299189-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2015-10-22 US disclosed
US-20150299189-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2015-10-22 US disclosed
EP-2915804-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF Toyama Chemical Co., Ltd. (JP) 2015-09-09 EP disclosed
EP-2915804-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF Toyama Chemical Co., Ltd. (JP) 2015-09-09 EP disclosed
WO-2014069510-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF 富山化学工業株式会社 (JP) 2014-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150299189-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF HRH4, CLIC4, KRT18 MEN1 3900/4885KMT2A 791/4885LMNA 3053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.